Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Rehabilitation in Hsct Publisher



Barkhordar M1 ; Nazeri I2 ; Maleki M3 ; Janbabai G4 ; Alizadehasl A3 ; Jolfayi AG3 ; Askarinejad A3 ; Kohansal E3 ; Azarfarin R3 ; Adimi S3
Authors

Source: Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation Published:2024


Abstract

Rehabilitative interventions play a crucial role in the care of patients who have undergone Hematopoietic Stem Cell Transplantation Hematopoietic Stem Cell Transplantation (HSCT) (HSCT), and a multidisciplinary rehabilitation Multidisciplinary rehabilitation program can help manage psychological challenges, improve physical and functional abilities and overall Quality Of Life Quality Of Life (QOL) in phases of HSCT's patients' treatment that associated with the transplant process. Historically, long-term Cardiovascular Disease Cardiovascular disease (CVD) and CVD risk factors such as Myocardial Infarction (MI), Heart Failure Heart failure (HF), and arrhythmias, are a major cause of morbidity and mortality among HSCT Hematopoietic Stem Cell Transplantation (HSCT) survivors; Cardiotoxicity Cardiotoxicity has been associated with chemotherapeutic agents used as part of primary treatment or preparative regimens in addition to cardiovascular issues related to HSCT. © Springer Nature Switzerland AG 2024. All rights reserved.
2. Burden of Cardiovascular Disease in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
3. Risk Factors and Mechanisms of Cardiotoxicity in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
Experts (# of related papers)
Other Related Docs
7. Long Term Cardiotoxicity Surveillance in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
8. Cardiotoxicity of Commonly Used Drugs in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
9. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
10. Hypertension in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
13. Post-Transplant Cyclophosphamide-Induced Cardiotoxicity: A Comprehensive Review, Journal of Cardiovascular and Thoracic Research (2024)
14. Peripheral Arterial Disease in Hsct, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
15. Pre-Hsct Cardiovascular Evaluation, Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation (2024)
20. The Relationship Between the Lifestyle of the Allogeneic Stem Cell Donors and the Number of Donated Cd34+ and Cd3+ Cells, International Journal of Hematology-Oncology and Stem Cell Research (2024)